National Institute of Allergy and Infectious Diseases (NIAID) ^Institute

Recent work: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19)

Technology: COVID Labs/Universities

Industry: COVID R&D

Headquarters: USA

Founded Date: N/A

Employees Number: N/A

Funding Status: N/A

National Institute of Allergy and Infectious Diseases (NIAID) Institute